Publications by authors named "Manuel Castano"

Claim this Profile
A
Anaphylaxis due to green beans (): A new phenotype?
Estela Menéndez Rivero, Manuel Prados Castaño, Isabel María Domínguez Romero, María José Martínez Martínez, Fernando Pineda De La Losa

Allergol Immunopathol (Madr)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis due to green beans (): a new phenotype?
Estela Menéndez Rivero, Manuel Prados Castaño, Isabel María Domínguez Romero, María José Martínez Martínez, Fernando Pineda De La Losa

Allergol Immunopathol (Madr)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study).
Cristina Gómez-Ayerbe, Rosario Palacios, Marisa Mayorga, Miguel Nicolas Navarrete, Sergio Ferra

Int J STD AIDS· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Manuel Castaño, Alberto Romero

Infect Dis Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Josefa Muñoz, Pepa Galindo

HIV Res Clin Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
María-Carlota Londoño, Mar Riveiro-Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[HIV in Spain 2017: policies for a new management of chronicity beyond virological control].
Julia Del Amo, Colin Campbell, Gemma Navarro, Ferran Segura, Ignacio Suárez

Rev Esp Salud Publica· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis due to roasted sunflower seeds with tolerance to raw sunflower seeds.
Marina Labella Álvarez, Teresa De Aramburu Mera, Krasimira Baynova, Borja Bartolomé Zavala, Manuel Prados Castaño

Ann Allergy Asthma Immunol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain.
Carmen M González-Domenech, Isabel Viciana, Luis Delaye, María Luisa Mayorga, Rosario Palacios

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study.
Enric Pedrol, Ana M Caro-Murillo, Manuel A Castaño, Melchor Riera, Julián Olalla

HIV Clin Trials· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].
Pompeyo Viciana-Fernández, Vicenç Falcó, Manuel Castaño, Ignacio de los Santos-Gil, Julián Olalla-Sierra

Enferm Infecc Microbiol Clin· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón

PLoS One· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.
Luis F López-Cortés, Manuel A Castaño, Miguel A López-Ruz, María J Rios-Villegas, José Hernández-Quero

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.
Isabel A Pérez-Hernández, Rosario Palacios, Marisa Mayorga, Carmen M González-Doménech, Manuel Castaño

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice.
Juan Pasquau, Luis López-Cortés, Maria Isabel Mayorga, Pompeyo Viciana, María Del Mar Arenas

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Characteristics of human immunodeficiency virus-infected patients without antiretroviral treatment in Spain: PICNIT study].
Pere Domingo Pedrol, Pompeyo Viciana Fernández, Manuel Castaño, Elena Ferrer Corbera

Med Clin (Barc)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.
José Ramón Blanco, Ana María Caro-Murillo, Manuel Angel Castaño, Julián Olalla, Pere Domingo

HIV Clin Trials· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report.
Macarena Piñero-Saavedra, Manuel Prados Castaño, Maria Ortega Camarero, Santiago Leguisamo Milla

Blood Coagul Fibrinolysis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to raltegravir in virologically suppressed in HIV-1-infected patients: a retrospective, multicenter, descriptive study.
Daniel Podzamczer, Esteban Martínez, Pere Domingo, Elena Ferrer, Pompeyo Viciana

Curr HIV Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.
Juan Macías, Francisco Orihuela, Antonio Rivero, Pompeyo Viciana, Manuel Márquez

J Antimicrob Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis